ImmunityBio’s Global Expansion Starts NOW ($75M Secured) скачать в хорошем качестве

ImmunityBio’s Global Expansion Starts NOW ($75M Secured)

ImmunityBio’s Global Expansion Starts NOW ($75M Secured) ImmunityBio has strengthened its balance sheet with $100 million in financing, including $75 million in non-dilutive funding from Oberland Capital. This significant capital infusion will support global expansion and the advancement of its immunotherapy pipeline. For investors interested in biotech stocks, this news highlights positive developments for IBRX and the broader biotech investing landscape. I use Interactive Brokers to buy most of the stocks I talk about. Create an account and get FREE stocks here: https://ibkr.com/referral/olivier574 Disclaimer This video is for educational and entertainment purposes only and is not investment advice. I am purely documenting my opinions on companies that interest me. I am not a Financial Advisor and I am not your Financial Advisor. You risk losing your money by investing. Please do your own due diligence and get advice from an expert. I am human and get things wrong. Tags $IBRX, IBRX, ImmunityBio stock, ibrx stock analysis, immunity bio stock, ImmunityBio, biotech stocks, biotech investing, pharma stocks, pharma investing, pharmaceutical stocks, pharmaceutical investing, biotech news, pharma news